Skip to main content
Industry News
PSMA-tracer PET/MRI shows promise in high-risk prostate cancer staging

Researchers found that whole-body Ga-68-PSMA-11 PET/MRI yielded similar positivity rate, sensitivity and specificity in determining the prevalence of extracapsular extension, lymph node metastases and seminal vesicle invasion, as well as better predicted the final T and N stages in patients with high-risk prostate cancer, compared with the Memorial Sloan Kettering Cancer Center nomogram and the Partin tables. The findings in the Journal of Nuclear Medicine suggest that using the approach in preoperative prostate cancer staging "might support treatment planning that may lead to improved patient outcomes," said researcher Dr. Andrei Gafita.

Full Story: